State Street Corp Amphastar Pharmaceuticals, Inc. Put Options Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$185 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$84.7 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$57.4 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$42.9 Million0.04% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.35MShares$42.1 Million0.12% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.53B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...